190 related articles for article (PubMed ID: 12426058)
61. Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.
Bao XQ; Wu LY; Wang XL; Sun H; Zhang D
Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):549-56. PubMed ID: 25678053
[TBL] [Abstract][Full Text] [Related]
62. Pathological proteins in Parkinson's disease: focus on the proteasome.
Snyder H; Wolozin B
J Mol Neurosci; 2004; 24(3):425-42. PubMed ID: 15655264
[TBL] [Abstract][Full Text] [Related]
63. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
64. [Alpha-synucleinopathies].
Ferrer I
Neurologia; 2001 Apr; 16(4):163-70. PubMed ID: 11412709
[TBL] [Abstract][Full Text] [Related]
65. Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein.
Rochet JC; Conway KA; Lansbury PT
Biochemistry; 2000 Sep; 39(35):10619-26. PubMed ID: 10978144
[TBL] [Abstract][Full Text] [Related]
66. Aggregation of alpha-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: a survey of six patients.
Piao YS; Wakabayashi K; Hayashi S; Yoshimoto M; Takahashi H
Clin Neuropathol; 2000; 19(4):163-9. PubMed ID: 10919347
[TBL] [Abstract][Full Text] [Related]
67. alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
Sidhu A; Wersinger C; Vernier P
FEBS Lett; 2004 May; 565(1-3):1-5. PubMed ID: 15135042
[TBL] [Abstract][Full Text] [Related]
68. Induction of alpha-synuclein aggregation by intracellular nitrative insult.
Paxinou E; Chen Q; Weisse M; Giasson BI; Norris EH; Rueter SM; Trojanowski JQ; Lee VM; Ischiropoulos H
J Neurosci; 2001 Oct; 21(20):8053-61. PubMed ID: 11588178
[TBL] [Abstract][Full Text] [Related]
69. Neuronal accumulation of alpha- and beta-synucleins in the brain of a GM2 gangliosidosis mouse model.
Suzuki K; Iseki E; Katsuse O; Yamaguchi A; Katsuyama K; Aoki I; Yamanaka S; Kosaka K
Neuroreport; 2003 Mar; 14(4):551-4. PubMed ID: 12657883
[TBL] [Abstract][Full Text] [Related]
70. Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers.
Yamin G; Uversky VN; Fink AL
FEBS Lett; 2003 May; 542(1-3):147-52. PubMed ID: 12729915
[TBL] [Abstract][Full Text] [Related]
71. Parkinson's disease: alpha-synuclein build-up explained.
Burton A
Lancet Neurol; 2004 Oct; 3(10):575. PubMed ID: 15461988
[No Abstract] [Full Text] [Related]
72. A short overview on the role of alpha-synuclein and proteasome in experimental models of Parkinson's disease.
Giorgi FS; Bandettini di Poggio A; Battaglia G; Pellegrini A; Murri L; Ruggieri S; Paparelli A; Fornai F
J Neural Transm Suppl; 2006; (70):105-9. PubMed ID: 17017516
[TBL] [Abstract][Full Text] [Related]
73. Role of alpha-synuclein in presynaptic dopamine recruitment.
Yavich L; Tanila H; Vepsäläinen S; Jäkälä P
J Neurosci; 2004 Dec; 24(49):11165-70. PubMed ID: 15590933
[TBL] [Abstract][Full Text] [Related]
74. Stress-Induced Cellular Clearance Is Mediated by the SNARE Protein ykt6 and Disrupted by α-Synuclein.
Cuddy LK; Wani WY; Morella ML; Pitcairn C; Tsutsumi K; Fredriksen K; Justman CJ; Grammatopoulos TN; Belur NR; Zunke F; Subramanian A; Affaneh A; Lansbury PT; Mazzulli JR
Neuron; 2019 Dec; 104(5):869-884.e11. PubMed ID: 31648898
[TBL] [Abstract][Full Text] [Related]
75. Rapid anionic micelle-mediated alpha-synuclein fibrillization in vitro.
Necula M; Chirita CN; Kuret J
J Biol Chem; 2003 Nov; 278(47):46674-80. PubMed ID: 14506232
[TBL] [Abstract][Full Text] [Related]
76. The Cleavage Effect of Mesenchymal Stem Cell and Its Derived Matrix Metalloproteinase-2 on Extracellular α-Synuclein Aggregates in Parkinsonian Models.
Oh SH; Kim HN; Park HJ; Shin JY; Kim DY; Lee PH
Stem Cells Transl Med; 2017 Mar; 6(3):949-961. PubMed ID: 28297586
[TBL] [Abstract][Full Text] [Related]
77. Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion.
Gosavi N; Lee HJ; Lee JS; Patel S; Lee SJ
J Biol Chem; 2002 Dec; 277(50):48984-92. PubMed ID: 12351643
[TBL] [Abstract][Full Text] [Related]
78. Neurons containing Alz-50-immunoreactive granules around the cerebral infarction: evidence for the lysosomal degradation of altered tau in human brain?
Ikeda K; Akiyama H; Arai T; Kondo H; Haga C; Tsuchiya K; Yamada S; Murayama S; Hori A
Neurosci Lett; 2000 Apr; 284(3):187-9. PubMed ID: 10773430
[TBL] [Abstract][Full Text] [Related]
79. Effect of lysosomal and ubiquitin-proteasome system dysfunction on the abnormal aggregation of α-synuclein in PC12 cells.
Wang R; Zhao J; Zhang J; Liu W; Zhao M; Li J; Lv J; Li Y
Exp Ther Med; 2015 Jun; 9(6):2088-2094. PubMed ID: 26136940
[TBL] [Abstract][Full Text] [Related]
80. Ultrastructure of eosinophilic inclusion bodies in the amygdala-parahippocampal region of aged squirrel monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin.
Forno LS; DeLanney LE; Irwin I; Langston JW
Neurosci Lett; 1995 Jan; 184(1):44-7. PubMed ID: 7739803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
